(Q38003705)

26 August 2017

miRNAs in breast cancer: ready for real time? (English)

1 reference

26 August 2017

Jonathan Krell

1

1 reference

26 August 2017

Adam E Frampton

2

1 reference

26 August 2017

Jimmy Jacob

3

1 reference

26 August 2017

Leandro Castellano

4

1 reference

26 August 2017

Justin Stebbing

5

1 reference

26 August 2017

1 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

13

1 reference

26 August 2017

6

1 reference

26 August 2017

709-719

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

26 August 2017

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

miR-21-mediated tumor growth

21 January 2018

1 reference

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

21 January 2018

1 reference

Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach

21 January 2018

1 reference

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer

21 January 2018

1 reference

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells

21 January 2018

1 reference

Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

21 January 2018

1 reference

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

21 January 2018

1 reference

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

21 January 2018

1 reference

Cancer metastasis: building a framework

21 January 2018

1 reference

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

Micromanagers of malignancy: role of microRNAs in regulating metastasis

21 January 2018

1 reference

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

21 January 2018

1 reference

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

21 January 2018

1 reference

Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain

21 January 2018

1 reference

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

21 January 2018

1 reference

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

Circulating microRNAs in breast cancer and healthy subjects

21 January 2018

1 reference

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

21 January 2018

1 reference

Circulating microRNAs: promising breast cancer Biomarkers.

21 January 2018

1 reference

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

21 January 2018

1 reference

Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer

21 January 2018

1 reference

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

21 January 2018

1 reference

Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors

21 January 2018

1 reference

MicroRNA profiling using RNA from microdissected immunostained tissue

21 January 2018

1 reference

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma

21 January 2018

1 reference

MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival

21 January 2018

1 reference

The role of microRNAs in liver cancer progression.

21 January 2018

1 reference

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer

21 January 2018

1 reference

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

21 January 2018

1 reference

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer

21 January 2018

1 reference

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

21 January 2018

1 reference

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.

21 January 2018

1 reference

Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells

21 January 2018

1 reference

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

21 January 2018

1 reference

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

MicroRNAs and cancer therapeutics

21 January 2018

1 reference

Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting

21 January 2018

1 reference

Developing therapeutic microRNAs for cancer

21 January 2018

1 reference

MicroRNAs as therapeutic targets in cancer

21 January 2018

1 reference

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

21 January 2018

1 reference

MicroRNAs as new therapeutic targets and tools in cancer.

21 January 2018

1 reference

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

miR-122 continues to blaze the trail for microRNA therapeutics

21 January 2018

1 reference

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

21 January 2018

1 reference

Stable knockdown of microRNA in vivo by lentiviral vectors

21 January 2018

1 reference

Targeting microRNAs with small molecules: from dream to reality

21 January 2018

1 reference

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

Current prospects for RNA interference-based therapies

21 January 2018

1 reference

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

Biomarker studies: a call for a comprehensive biomarker study registry

21 January 2018

1 reference

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.

21 January 2018

1 reference

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics

21 January 2018

1 reference

WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade

21 January 2018

1 reference

Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis

21 January 2018

1 reference

Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis

21 January 2018

1 reference

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

21 January 2018

1 reference

miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.

21 January 2018

1 reference

Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer

21 January 2018

1 reference

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

21 January 2018

1 reference

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.12.15

1 reference

26 August 2017

1 reference